Today: 7 February 2026
Subscribe
Browse Category

Investing News 30 December 2025

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake

NEW YORK, December 30, 2025, 16:03 ET — After-hours Nvidia (NVDA.O) shares edged lower on Tuesday after a report said the AI-chip leader is in advanced talks to buy Israel-based AI startup AI21 Labs in a deal estimated at $2 billion to $3 billion. The stock ended the regular session down about 0.3% at $187.65. Reuters+1 The report matters because Nvidia has been pushing deeper into the broader AI stack — not just chips, but the software and talent that help companies build and run AI systems. A move for AI21 would add an AI model builder to Nvidia’s orbit
30 December 2025
······
Meta stock closes up on Manus AI agent deal — what investors are watching next

Meta stock closes up on Manus AI agent deal — what investors are watching next

NEW YORK, December 30, 2025, 16:04 ET — After-hours Meta Platforms, Inc. shares closed higher on Tuesday after the Facebook owner said it would acquire Chinese-founded artificial intelligence startup Manus, a move that put fresh focus on the company’s push into advanced AI features. Meta ended the regular session at $666.49, up 1.2%. Yahoo Finance+1 The purchase matters because “AI agents” — software designed to carry out multi-step tasks with limited instructions — are emerging as the next battleground for consumer and business AI, and investors are looking for clear product paths rather than research demos. Manus markets itself as
30 December 2025
·····
Tesla stock today: TSLA slips after company posts delivery-consensus table ahead of Friday numbers

Tesla stock today: TSLA slips after company posts delivery-consensus table ahead of Friday numbers

NEW YORK, December 30, 2025, 16:07 ET — After-hours Tesla shares fell about 0.8% on Tuesday to $455.75 after the electric-vehicle maker published a company-compiled analyst consensus that points to a weaker fourth-quarter delivery count. The timing matters: Tesla is expected to report its official fourth-quarter and full-year production and delivery tally on Friday (Jan. 2), and analysts expect a year-over-year decline after U.S. tax credits expired in September. Tesla’s cheaper “Standard” versions of the Model Y and Model 3, launched in October, have not erased worries about demand and competition. Reuters Deliveries are Wall Street’s cleanest read on near-term
30 December 2025
·····
Synopsys stock slips today as SNPS faces lawsuit deadline in thin year-end trade

Synopsys stock slips today as SNPS faces lawsuit deadline in thin year-end trade

NEW YORK, December 30, 2025, 15:44 ET — Regular session Synopsys shares were down $3.06, or 0.6%, at $475.91 in late-afternoon trade, after moving between $472.05 and $483.14 on the day. The chip-design software company sells electronic design automation tools — software used to design and verify semiconductors — and its stock has been sensitive to shifts in AI-linked tech sentiment into year-end. That sensitivity is getting tested on a holiday-thinned session when small headlines can drive outsized moves. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at
30 December 2025
····
Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale

Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale

NEW YORK, December 30, 2025, 15:30 ET — Regular session. Shares of Terns Pharmaceuticals, Inc. fell 2.8% to $40.34 in afternoon trading on Tuesday, after swinging between $39.99 and $41.98. The pullback puts the stock back around $40, the price used in the company’s recent upsized equity offering — a level traders often watch after a big deal resets supply and demand. That matters now because Terns’ December financing and trial update put new attention on how quickly the biotech can turn early leukemia data into larger studies, while also giving it a much longer cash runway. Biotech shares were
30 December 2025
·····
Bloom Energy stock slips today as Clear Street lifts target but keeps Hold in thin year-end trade

Bloom Energy stock slips today as Clear Street lifts target but keeps Hold in thin year-end trade

NEW YORK, December 30, 2025, 15:25 ET — Regular session Bloom Energy Corp shares fell on Tuesday as year-end positioning and a soft tape for growth stocks kept pressure on the fuel-cell maker. The stock was down 1.7% at $86.93 in afternoon trading. The move matters because trading volumes have stayed light in the holiday-truncated week, which can amplify intraday swings in volatile names. U.S. stocks were subdued in choppy trade, with gains in communication services capped by declines in technology and financials, Reuters reported. Reuters Analysts are also recalibrating their assumptions for companies tied to data-center power demand, a
30 December 2025
·····
Hut 8 stock today: Why HUT is down even as bitcoin edges higher

Hut 8 stock today: Why HUT is down even as bitcoin edges higher

NEW YORK, December 30, 2025, 15:21 ET — Regular session Hut 8 Corp (HUT) shares fell 3.1% to $47.31 in afternoon trading on Tuesday, after moving between $47.18 and $49.26 earlier in the session. About 2.26 million shares had traded. The pullback matters because Hut 8 sits at the intersection of two fast-moving themes: bitcoin-linked equities and the market’s scramble for data centers to run artificial intelligence (AI) workloads. That mix has made the stock prone to sharp, sentiment-driven swings. The broader backdrop has been choppy. U.S. stocks were subdued on Tuesday and trading volumes remained thin in the holiday-truncated
30 December 2025
·····
Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

NEW YORK, December 30, 2025, 14:30 ET — Regular session Shares of Kymera Therapeutics fell about 3% to $77.94 in afternoon trading on Tuesday, lagging a broader biotech dip. The SPDR S&P Biotech ETF was down about 1.4%, while the iShares Nasdaq Biotechnology ETF slipped about 1.1%. The pullback matters because Kymera has been one of the sector’s higher-volatility names this month, after a surge tied to new clinical data and a subsequent stock sale that increased its share count. With most of its next major readouts still far off, investors have been quick to reprice the stock around financing
30 December 2025
·····
SoFi stock today: SOFI barely moves after Fed minutes; what investors watch next

SoFi stock today: SOFI barely moves after Fed minutes; what investors watch next

NEW YORK, December 30, 2025, 3:01 PM ET — Regular session SoFi Technologies, Inc. shares were down 0.1% at $26.80 on Tuesday afternoon, after trading between $26.65 and $27.14. The Federal Reserve released minutes from its Dec. 9–10 meeting at 2:00 p.m. ET, putting fresh attention on how quickly policymakers might cut interest rates again. Federal Reserve That matters for SoFi because investors tend to treat the fintech lender as sensitive to shifts in borrowing costs, which can influence consumer demand for loans and a lender’s funding expenses. Trading across Wall Street was choppy in a holiday-shortened week, with investors
30 December 2025
····
Why Western Digital stock is down today: WDC slides as year-end rotation cools AI-hardware trades

Why Western Digital stock is down today: WDC slides as year-end rotation cools AI-hardware trades

NEW YORK, December 30, 2025, 3:00 PM ET — Regular session Western Digital Corp shares fell 1.7% to $176.55 on Tuesday, after opening higher and sliding through the afternoon. The stock touched $181.34 earlier in the session before dipping as low as $176.31. The pullback lands after a standout year for the data-storage maker, whose shares have surged about 303% in 2025, making it one of the S&P 500’s biggest gainers. That steep run has made the stock a frequent target for late-December portfolio reshuffling. Barron’s Broader U.S. indexes were little changed in choppy, light-volume trading, with investors repositioning inside
30 December 2025
·····
Carvana stock drifts in thin trade after Fed minutes — what CVNA investors are watching

Carvana stock drifts in thin trade after Fed minutes — what CVNA investors are watching

NEW YORK, December 30, 2025, 14:52 ET — Regular session Carvana Co shares edged lower on Tuesday afternoon, trading down less than 0.1% at $433.32, as year-end portfolio shifts kept risk appetite uneven across consumer names. The muted move matters because Carvana has become a high-beta momentum stock after a sharp turnaround, and thin holiday volumes can exaggerate day-to-day swings even when headlines are light. Investors also had fresh Federal Reserve minutes to digest. Rate expectations matter for used-car demand because financing costs influence monthly payments, a key factor for many buyers. Broader U.S. markets were subdued in choppy trading,
30 December 2025
······
Why Caris Life Sciences (CAI) stock is down today as biotech slips

Why Caris Life Sciences (CAI) stock is down today as biotech slips

NEW YORK, December 30, 2025, 14:58 ET — Regular session Caris Life Sciences shares were down about 1.8% at $27.44 as of 2:41 p.m. ET, after trading between $27.00 and $27.97 during Tuesday’s session. The drop came as biotech stocks underperformed, with the SPDR S&P Biotech ETF down about 1.5% and the iShares Nasdaq Biotechnology ETF off about 1.2%. The S&P 500 was little changed and the Nasdaq was flat, Reuters data showed. Reuters That matters for Caris because the newly public cancer diagnostics company tends to move with shifts in risk appetite for healthcare growth names, even when there
30 December 2025
···
1 … 295 296 297 298 299 … 585

Stock Market Today

Halma share price: Friday’s lift sets up what investors watch next week

Halma share price: Friday’s lift sets up what investors watch next week

7 February 2026
Halma shares closed up 0.7% at 3,548 pence on Friday, valuing the group at about £13.4 billion. The Bank of England held rates at 3.75% in a split vote, keeping rate-cut speculation in focus. Halma’s next trading update is set for March 12. The FTSE 100 ended the week up 0.6%, lifted by bank stocks.
Diageo share price slips into the weekend as investors eye Feb. 25 results

Diageo share price slips into the weekend as investors eye Feb. 25 results

7 February 2026
Diageo shares closed down 1.48% at 1,760 pence on Friday, trailing a 0.59% gain in the FTSE 100. An updated analyst consensus points to a 2.0% fall in first-half organic net sales ahead of interim results due Feb. 25. Trading volume was light, and the stock remains over 22% below its 52-week high.
National Grid share price: what to know before London reopens after BoE signal

National Grid share price: what to know before London reopens after BoE signal

7 February 2026
National Grid shares closed at 1,285 pence in London on Friday, up 0.23%. The Bank of England held rates at 3.75% after a close vote, signaling possible cuts if inflation falls. National Grid announced a wireless power transmission study with Space Solar and marked five years of IFA2 interconnector operations. Its U.S. ADR ended at $88.06, up $1.17.
BAE Systems share price rises into weekend — what to watch before Monday’s London open

BAE Systems share price rises into weekend — what to watch before Monday’s London open

7 February 2026
BAE Systems shares closed up 1.2% at 1,879 pence on Friday, tracking gains in European defence stocks. The company’s market value stands near £54.8 billion. Investors await BAE’s full-year results on Feb. 18 for updates on cash returns and orders. GXO Logistics renewed and expanded its contract to support BAE’s Type 26 frigate program in Scotland.
Go toTop